Osteocalcin, β-cross laps, parathormone, serum phosphate, and vitamin D were equal in both studied populations, suggesting that bone metabolism turnover in MPN patients may not be the most important pathophysiological mechanism for sOA development. The gene discussed is BGLAP; the disease is myeloproliferative neoplasm.